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Summary
Apoptosis and autophagy are both tightly regulated
biological processes that play a central role in tissue
homeostasis, development, and disease. The anti-
apoptotic protein, Bcl-2, interacts with the evolution-
arily conserved autophagy protein, Beclin 1. However,
little is known about the functional significance of
this interaction. Here, we show that wild-type Bcl-2
antiapoptotic proteins, but not Beclin 1 binding de-
fective mutants of Bcl-2, inhibit Beclin 1-dependent
autophagy in yeast and mammalian cells and that
cardiac Bcl-2 transgenic expression inhibits auto-
phagy in mouse heart muscle. Furthermore, Beclin 1
mutants that cannot bind to Bcl-2 induce more au-
tophagy than wild-type Beclin 1 and, unlike wild-type
Beclin 1, promote cell death. Thus, Bcl-2 not only
functions as an antiapoptotic protein, but also as an
antiautophagy protein via its inhibitory interaction
with Beclin 1. This antiautophagy function of Bcl-2
may help maintain autophagy at levels that are com-
patible with cell survival, rather than cell death.
Introduction
Autophagy is an evolutionarily conserved pathway that
involves the sequestration and delivery of cytoplasmic
material to the lysosome, where it is degraded and re-*Correspondence: beth.levine@utsouthwestern.edu
8 Present address: Department of Molecular Oncology, Genentech
Inc., 1 DNA Way, MS #42, South San Francisco, California 94080.cycled. In theory, autophagy may help promote cell sur-
vival, either by purging the cell of damaged organelles,
toxic metabolites, and intracellular pathogens or by
generating the intracellular building blocks required to
maintain vital functions during nutrient-limiting condi-
tions. However, in theory, autophagy may also promote
cell death through excessive self-digestion and degra-
dation of essential cellular constituents. Despite recent
advances in understanding its molecular mechanisms
and biological functions (Levine and Klionsky, 2004), it
is unclear whether autophagy acts fundamentally as a
cell survival or cell death pathway—or both.
Morphologic and genetic studies have yielded con-
flicting results regarding the role of autophagy in cell
survival and cell death. When intracellular nutrients are
limited, as in the case of starvation or growth factor
deprivation, autophagy genes are essential to maintain
cellular ATP energy production, macromolecular syn-
thesis, and cell survival (Lum et al., 2005). The absence
of autophagy genes results in death in nitrogen-starved
yeast, starvation-induced chlorosis in plants, death of
starved Dictyostelium, defective dauer development in
C. elegans, early neonatal lethality in mice following in-
terruption of the placental food supply, accelerated
death of growth factor-deprived, apoptosis-resistant fi-
broblasts, and apoptosis of starved HeLa cells (Boya
et al., 2005; Kuma et al., 2004; Levine and Klionsky,
2004; Liu et al., 2005; Lum et al., 2005). Furthermore,
the protective actions of autophagy against infection
with intracellular pathogens, protein aggregation dis-
eases, and aging in metazoan organisms (Levine and
Yuan, 2005) are likely to represent a prosurvival function
at the cellular level.
Paradoxically, autophagy may also represent a form
of nonapoptotic cell death, which has been implicated
in the demise of a variety of cell types during develop-
ment, tissue homeostasis, and in response to toxic
stimuli (Lockshin and Zakeri, 2004). In most studies, au-
tophagic cell death has been defined by morphologic
criteria, and it is unclear whether autophagy directly
contributes to death or is a failed effort to preserve cell
viability. However, RNAi directed against the autophagy
genes, atg7 or beclin 1, suppresses death in mouse
L929 fibroblastic cells treated with the caspase inhibi-
tor, ZVAD, and RNAi against atg5 or beclin 1 sup-
presses death in bax−/−, bak−/− murine embryonic fibro-
blasts (MEFs) treated with etoposide or staurosporine
(Shimizu et al., 2004; Yu et al., 2004). Downregulation of
Atg5 expression or ectopic expression of a dominant-
negative Atg5 mutant blocks IFN-γ-induced death in
HeLa cells (Pyo et al., 2005). Thus, autophagy genes
can be involved in the death execution process.
Moreover, complex interrelationships are likely to ex-
ist between autophagy and the apoptotic cell death
pathway (Levine and Yuan, 2005). Regulators of apo-
ptosis activation also function as regulators of auto-
phagy activation, including the sphingolipid, ceramide,
the death-receptor signaling molecules, TRAIL and FADD,
and the serine/threonine death kinases, DAPk and
DRP-1. Similarly, some signaling pathways, such as the
Cell
928Figure 1. Human Bcl-2 and Viral Bcl-2 Interact
with Beclin 1 and Inhibit Beclin 1-Dependent
Autophagy in Starved atg6-Disrupted Yeast
(A) Yeast two-hybrid assay interactions be-
tween Beclin 1/Atg6 autophagy proteins and
Bcl-2 antiapoptotic proteins. + indicates
positive reaction at 15 min; − indicates nega-
tive reaction at 12 hr.
(B) Quantitation of autophagy in atg6 yeast
cotransformed with the plasmids encoding
the indicated gene products. Results shown
represent mean ±SEM percentage of cells with
autophagic bodies for combined data from
six independent experiments. Asterisk denotes
p < 0.001 when compared to yeast cells
cotransformed with pMS424/Beclin 1 and
empty p426GPD.Class I PI3K/Akt signaling pathway, inhibit both apopto-
sis and autophagy. Morphologic features of both au-
tophagic and apoptotic cell death can be observed in
the same cell (e.g., insect glands during metamorpho-
ses), and in the case of steroid-triggered salivary gland
death in Drosophila, caspase inhibition blocks the death
of cells exhibiting an autophagic morphology. Auto-
phagy may activate apoptosis, and conversely, genetic
inhibition of autophagy can activate apoptotic death in
nutrient-starved mammalian cells.
The interaction between the antiapoptotic protein,
Bcl-2, and the autophagy protein, Beclin 1, represents
a potentially important point of convergence of the apo-
ptotic and autophagic machinery. Beclin 1, the mamma-
lian ortholog of yeast Atg6/Vps30, was first identified in
a yeast two-hybrid screen as a Bcl-2-interacting protein
(Liang et al., 1998) and is a haploinsufficient tumor-sup-
pressor gene that is frequently monoallelically deleted
in human sporadic breast, ovarian, and prostate cancer
(Levine and Klionsky, 2004). Beclin 1 is part of a Class
III PI3K complex that participates in autophagosome
formation, mediating the localization of other auto-
phagy proteins to the preautophagosomal membrane
(Kihara et al., 2001). Although the Bcl-2 binding domain
of Beclin 1 is required for the antiviral and prosurvival
effects of Beclin 1 during lethal murine encephalitis (Li-
ang et al., 1998), the biological significance of the in-
teraction between Bcl-2 and Beclin 1 has not been ex-
plored.
In this study, we use yeast and mammalian cells to
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Bvaluate whether the interaction between Bcl-2 and
eclin 1 regulates starvation-induced autophagy. We
ound that cellular and virally encoded Bcl-2 proteins
ind to Beclin 1 and disrupt its autophagy function. In
he absence of Bcl-2 binding, Beclin 1 mutants induce
xcessive autophagy and promote cell death. Together,
hese findings suggest that the Beclin 1-Bcl-2 complex
unctions as a brake on levels of autophagy and au-
ophagy gene-dependent cell death.
esults
ellular and Viral Bcl-2 Inhibit Beclin 1-Dependent
utophagy in Yeast
east disrupted of the beclin 1 ortholog, ATG6, are defi-
ient in starvation-induced autophagy, and this defect
an be complemented by orthologs from higher eu-
aryotes (Liang et al., 1999; Melendez et al., 2003; Liu
t al., 2005). In a yeast two-hybrid assay, we found that
oth cellular Bcl-2 and Bcl-2 encoded by Kaposi’s
arcoma-associated herpesvirus (KSHV v-Bcl-2) bind
trongly to Beclin 1, but not to yeast Atg6 (Figure 1A).
herefore, by measuring starvation-induced autophagy
n atg6 yeast cotransformed with plasmids expressing
ither wild-type Beclin 1 and Bcl-2 or mutants of Beclin
and Bcl-2 that fail to bind to each other, we investi-
ated whether the interaction between Bcl-2-like pro-
eins and Beclin 1 alters the autophagy function of
eclin 1.
As previously shown, wild-type Beclin 1 restores star-
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Two Beclin 1 mutants containing substitution mutations
within the Bcl-2 binding domain of Beclin 1 (amino
acids 88–150; Liang et al., 1998) also rescue autophagy
in atg6 yeast (Figure 1B). These include a mutant Bec-
lin 1 protein (Beclin 1 F123A) which is defective in Bcl-2
binding and a control mutant Beclin 1 protein (Beclin 1
I125A) that does not affect binding to Bcl-2 (Figure 1A).
Beclin 1 F123A and Beclin 1 I125A were expressed in
yeast at similar levels as those observed for wild-type
Beclin 1 (data not shown).
Cellular Bcl-2 and KSHV v-Bcl-2 both significantly in-
hibited the ability of either wild-type Beclin 1 or the
control mutant Beclin I125A to rescue starvation-
induced autophagy in atg6D yeast (Figure 1B) (p <
0.001, t test). In contrast, cellular Bcl-2 and KSHV
v-Bcl-2 had no effect on autophagy rescue by the Bcl-2
binding defective mutant, Beclin 1 F123A, suggesting
that a direct interaction with Beclin 1 is required for
Bcl-2 and KSHV v-Bcl-2-mediated inhibition of Beclin
1-dependent autophagy. Furthermore, a mutation in the
BH1 domain of Bcl-2, Bcl-2 G145A, that blocks the
yeast two-hybrid interaction of Bcl-2 with Beclin 1 (Fig-
ure 1A), also blocks the ability of Bcl-2 to antagonize
autophagy in atg6 yeast expressing either wild-type
Beclin 1 or the control mutant Beclin 1 I125A (Figure
1B). This result, together with the failure of wild-type
Bcl-2 and KSHV v-Bcl-2 to block autophagy mediated
by the Bcl-2 binding defective mutant of Beclin 1, de-
monstrates a role for Bcl-2-Beclin 1 interactions in an-
tagonizing the autophagy function of Beclin 1.
Cellular and Viral Bcl-2 Inhibit Beclin 1-Dependent
Autophagy in Mammalian Cells
Previous FRET analysis showed that Bcl-2 and Beclin
1 can interact in mammalian cells (Liang et al., 1998).
To confirm these findings biochemically and identify
mutations that block the interaction, we performed
coimmunoprecipitations of HEK293 cells transiently
transfected with Beclin 1 and Bcl-2-like proteins (Fig-
ures 2A and 2B). Wild-type Bcl-2, but not a BH1 domain
mutant of Bcl-2 (Bcl-2 G145A) or a BH2 domain mutant
of Bcl-2 (Bcl-2 W188A), coimmunoprecipitated with
Beclin 1 (Figure 2A). KSHV vBcl-2 also coimmunopreci-
pitated with Beclin 1 (Figure 2B).
To evaluate whether Bcl-2 and KSHV v-Bcl-2 inhibit
Beclin 1-dependent autophagy in mammalian cells, we
used human MCF7 breast carcinoma cells derived from
a tumor with a monallelic deletion of beclin 1 (Holt et
al., 1996). Most MCF7 subclones express low or unde-
tectable levels of endogenous Beclin 1 (Liang et al., 1999;
Scarlatti et al., 2004; Figure 2C) and fail to increase au-
tophagic activity in response to starvation unless Bec-
lin 1 is ectopically expressed (Furuya et al., 2005; Liang
et al., 1999, 2001). Therefore, we assessed the effects
of cellular Bcl-2 and v-Bcl-2 expression on the ability
of Beclin 1 to promote starvation-induced autophagy in
MCF7 cells. To measure autophagy, we expressed the
fluorescent autophagy marker, GFP-LC3, a highly spe-
cific marker of mammalian autophagy (Mizushima et al.,
2004). When autophagy is stimulated, GFP-LC3 redis-
tributes from a diffuse cytoplasmic pattern to form
punctate structures that label preautophagosomal and
autophagosomal membranes.As expected, we found that autophagy is increased
following nutrient deprivation in MCF7 cells expressing
beclin 1 (MCF7.beclin 1 cells) but not in MCF7.control
cells (p < 0.001; t test). Expression of Bcl-2 or KSHV
v-Bcl-2 inhibited starvation-induced autophagy in
MCF7.beclin 1 cells (Figures 2D and 2E; p < 0.001 for
Bcl-2 or KSHV v-Bcl-2 versus empty vector; t test). Nei-
ther Bcl-2 nor KSHV v-Bcl-2 altered autophagy levels
in MCF7.control cells (data not shown). In contrast to
the effects of wild-type Bcl-2, expression of Bcl-2 mu-
tants that fail to bind to Beclin 1, Bcl-2 G145A or Bcl-2
W188A, did not inhibit autophagy in starved MCF7.
beclin 1 cells, despite similar levels of expression as wild-
type Bcl-2 (Figure 2C). Thus, cellular and viral Bcl-2
block Beclin 1-dependent autophagy in both yeast and
mammalian cells.
To evaluate the effects of Bcl-2 on autophagy in an
independent cell line, we used human colon carcinoma
cells that are stably transfected with Bcl-2 (HT-29 Bcl-2
cells; Lacour et al., 2003). HT-29 control cells express
detectable levels of Beclin 1 but not Bcl-2 (Figure 3A)
and can increase autophagic activity following amino
acid deprivation (Pattingre et al., 2003). In HT-29 Bcl-2
cells, Bcl-2 coimmunoprecipitates with endogenous
Beclin 1 (Figure 3A). Unlike HT-29 control cells, HT-29
Bcl-2 cells do not increase autophagic activity follow-
ing amino acid starvation, as measured by either the
quantitation of GFP-LC3-positive dots (Figure 3B) or by
quantitative electron microscopy (Figures 3C and 3D).
To verify that the reduced number of autophagosomes
in starved HT-29 Bcl-2 versus HT-29 control cells repre-
sents decreased autophagy, rather than an accelerated
disappearance of GFP-LC3-positive autophagosomes,
we also measured the degradation of long-lived pro-
teins (Figure 3E). In HT-29 control cells but not in HT-29
Bcl-2 cells, there was a significant increase in proteoly-
sis of long-lived cellular proteins during starvation. To-
gether, these results suggest that Bcl-2 blocks auto-
phagy at a stage prior to association of LC3 with the
preautophagosomal membrane.
Bcl-2 Inhibits the Formation of the Beclin
1/hVps34 PI3K Complex and Beclin
1-Associated Class III PI3K Activity
Beclin 1 functions in autophagy as part of a complex
with hVps34/Class III PI3K (Kihara et al., 2001). Genera-
tion of PI3P by the Beclin 1/hVps34 complex is thought
to be important in mediating the localization of other
autophagy proteins to preautophagosomal membranes.
Since Bcl-2 downregulates Beclin 1-dependent au-
tophagy, we evaluated the effects of Bcl-2 expression
on Beclin 1/hVps34 complex formation and activity in
HT-29 cells.
HT-29 Bcl-2 cells expressed similar levels of both
Beclin 1 and hVps34 as HT-29 control cells, but in HT-
29 Bcl-2 cells, less hVps34 coimmunoprecipitated with
Beclin 1 (Figure 3F). This suggested that Bcl-2 over-
expression interferes with the formation of the Beclin
1/hVps34 complex. To confirm that the functional activ-
ity of this complex was decreased in HT-29 Bcl-2 cells,
we labeled the Class III PI3K product, PI3P, with a GFP-
2xFYVE domain plasmid (Viera et al., 2001). We ob-
served significantly more colocalization of Beclin 1 with
Cell
930Figure 2. Human Bcl-2 and Viral Bcl-2 Inhibit Beclin 1-Dependent Autophagy in MCF7 Human Breast Carcinoma Cells
(A and B) Coimmunoprecipitation of Beclin 1 and Bcl-2 (A) or KSHV vBcl-2 (B) in HEK293 cells cotransfected with indicated plasmids.
(C) Western blot analyses of MCF7.control cells and MCF7.beclin 1 cells transfected with the indicated Bcl-2 expression plasmids. The
Western blot shown to detect Bcl-2 represents a 3 s exposure of the enhanced chemoluminescence. Bcl-2 is detectable in the MCF7.control
cells and the MCF7.beclin 1 cells transfected with empty vector with a longer blot exposure (data not shown).
(D) Representative images of GFP-LC3 staining in MCF7.control and MCF7.beclin 1 cells cotransfected with GFP-LC3 and indicated plasmid.
Arrows denote representative cells containing GFP-LC3 dots (i.e., autophagosomal structures).
(E) Light-microscopic quantitation of autophagy in MCF7.control cells and MCF7.beclin 1 cells cotransfected with GFP-LC3 and plasmid
indicated below x axis. Results shown represent mean ±SEM for combined data from five independent experiments.GFP-2xFYVE in HT-29 control as compared to in HT-29
Bcl-2 cells (Figure 3G). These findings suggest that Bcl-2
inhibits the formation of the autophagy-promoting Bec-
lin 1/hVps34 complex and decreases Beclin 1-associ-
ated Class III PI3K activity.
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he Beclin 1 binding partner, hVps34/Class III PI3K, is
redominantly found on endosomes and the trans-
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931Golgi network (TGN; Gillooly et al., 2000), whereas Bcl-2
is predominantly found on the outer mitochondrial and
ER membranes (Germain and Shore, 2003). While over-
expressed Beclin 1 colocalized with Bcl-2 in the mito-
chondria and ER in COS7 cells (Liang et al., 1998), en-
dogenous Beclin 1 has been reported to localize
predominantly to the TGN (Kihara et al., 2001). Since
Bcl-2 is not found in the TGN, we hypothesized that
endogenous Beclin 1 must also localize to other sub-
cellular compartments where Bcl-2 is found. Using con-
focal microscopy, we found that endogenous Beclin 1
in HT-29 cells colocalizes both with dyes that label
mitochondria and that label ER (Figure 4A). We also de-
tected Beclin 1 in the mitochondria and ER in subcellu-
lar fractionation experiments in HT-29 cells (data not
shown).
Next, we evaluated whether Bcl-2 exerts its antiau-
tophagy activity at the mitochondria and/or ER. We
used Bcl-2 mutants that have restricted subcellular lo-
calization, including a mutant in which the C-terminal
hydrophobic sequence of Bcl-2 is exchanged for an
equivalent sequence from ActA (resulting in outer mito-
chondrial membrane-specific localization) and a mu-
tant in which the C-terminal sequence is exchanged for
a sequence from cytochrome b5 (resulting in ER-spe-
cific localization; Zhu et al., 1996). In HT-29 cells, similar
levels of Bcl-2 protein expression were observed in
cells cotransfected with GFP-LC3 and wild-type Bcl-2,
mitochondrial-targeted Bcl-2, or ER-targeted Bcl-2 (Fig-
ure 4B). However, mitochondrial-targeted Bcl-2 did not
inhibit starvation-induced autophagy, whereas ER-tar-
geted Bcl-2 inhibited starvation-induced autophagy as
effectively as wild-type Bcl-2 (Figure 4C). Similar results
were observed in MCF7.beclin 1 cells expressing wild-
type, mitochondrial-targeted, or ER-targeted Bcl-2 (Fig-
ures 4D and 4E). Thus, in two different cell types, Bcl-2
functions at the ER and not at the mitochondria to in-
hibit starvation-induced autophagy.
Endogenous Bcl-2 Binds to Endogenous Beclin 1
in a Nutrient-Dependent Manner and Downregulates
Levels of Starvation-Induced Autophagy
Our data in MCF7 and HT-29 cells indicate that Bcl-2
and KSHV v-Bcl-2 enforced expression inhibit Beclin
1-dependent starvation-induced autophagy. To ad-
dress whether endogenous Bcl-2 also interacts with
Beclin 1 and regulates starvation-induced autophagy,
we performed studies in an autophagy-competent cell
line, HeLa cells, that expresses detectable endogenous
levels of both Bcl-2 and Beclin 1 (Figure 5A). We found
that endogenous Bcl-2 binds to endogenous Beclin 1
and that this interaction is regulated by cellular nutrient
status (Figure 5A). During autophagy-inducing condi-
tions (i.e., starvation), minimal levels of Bcl-2 coimmu-
noprecipitate with Beclin 1; during autophagy-inhibitory
conditions (i.e., growth in nutrient-rich media), high
levels of Bcl-2 coimmunoprecipitate with Beclin 1; and
during growth in normal media, intermediate levels of
Bcl-2 coimmunoprecipitate with Beclin 1. This pattern
suggests that the differential binding of endogenous
Bcl-2 and Beclin 1 may be a physiological mechanism
to regulate autophagy induction in response to star-
vation.To confirm that endogenous Bcl-2 negatively regu-
lates starvation-induced autophagy in HeLa cells, we
used a hairpin siRNA to knock down Bcl-2 expression.
We confirmed that bcl-2 siRNA, but not a control
scrambled siRNA, results in a decrease in the levels of
Bcl-2 expression (Figure 5B). This decrease was ob-
served at 48 but not at 24 hr after transfection. At the
48 hr time point when endogenous Bcl-2 protein levels
were reduced, cells cotransfected with GFP-LC3 and
bcl-2 siRNA had approximately twice as many autopha-
gosomes per cell during starvation as cells cotrans-
fected with GFP-LC3 and a control siRNA (p = 0.007; t
test; Figure 5C). This increased autophagy in HeLa cells
following bcl-2 gene silencing demonstrates that en-
dogenous Bcl-2 negatively regulates levels of starva-
tion-induced autophagy.
Bcl-2 Inhibits Starvation-Induced Autophagy
in Mouse Cardiac Muscle
We evaluated whether Bcl-2 can also regulate autoph-
agy during starvation in vivo. Previously, Mizushima et
al. (2004) showed that prolonged starvation is a potent
activator of autophagy in the cardiac muscle of mice
expressing the transgenic fluorescent autophagy marker,
GFP-LC3. Therefore, we crossed GFP-LC3 transgenic
mice with mice that transgenically express human Bcl-2
under the control of the αMHC promoter (Imahashi et
al., 2004; Figure 5A). Under normal nutrient conditions,
we did not detect autophagy (as measured by GFP-
LC3 dots) in either control or Bcl-2 transgenic/GFP-LC3
mice (data not shown). Following prolonged starvation,
we observed a significant reduction in the magnitude
of autophagy in Bcl-2 transgenic/GFP-LC3 mice as
compared to in non-Bcl-2 transgenic control/GFP-LC3
littermates (Figures 6E and 6F; p = 0.008; t test). Thus,
transgenic Bcl-2 expression downregulates starvation-
induced autophagy in cardiac muscle.
Beclin 1 Mutants that Cannot Bind to Bcl-2 Induce
Excess Levels of Autophagy and Are Prodeath
To further address the role of Beclin 1-Bcl-2 interac-
tions in autophagy regulation, we compared the levels
of autophagy induction in MCF7 cells transfected with
wild-type Beclin 1 or Bcl-2 binding defective mutants
of Beclin 1. We used three mutants of Beclin 1, includ-
ing Beclin 1 lacking amino acids 88–150 (Beclin 1Bcl-
2BD), Beclin 1 F123A, and Beclin 1 I125A. Similar to our
findings in yeast two-hybrid assays (Liang et al., 1998;
Figure 1A), Beclin 1Bcl-2BD and Beclin 1 F123A were
unable to coimmunoprecipitate Bcl-2 in transfected
HEK293 cells, whereas Beclin 1 I125A coimmunopre-
cipitated Bcl-2 as efficiently as wild-type Beclin 1 (Fig-
ure 6A).
The number of autophagosomes per cell was ap-
proximately doubled in nutrient-starved MCF7 cells
expressing Bcl-2 binding defective mutants of Beclin 1
(e.g., Beclin 1Bcl-2BD and Beclin 1 F123A) as com-
pared to in nutrient-starved MCF7 cells expressing
Beclin 1 proteins that can bind to Bcl-2 (e.g., wild-type
Beclin 1 or Beclin 1 I125A) (Figure 6B; p = 0.026 for Bec-
lin 1Bcl-2 BD versus wild-type Beclin 1; p = 0.034 for
Beclin 1 F123A versus wild-type Beclin 1; t test). The
number of autophagosomes per cell was also signifi-
Cell
932Figure 3. Bcl-2 Inhibits Autophagy in HT-29 Human Colon Carcinoma Cells, Partially Blocks the Interaction of Beclin 1 with hVps34, and
Decreases Beclin 1-Associated Class III PI3K Activity
(A) Coimmunoprecipitation of Beclin 1 and Bcl-2 in HT-29 Bcl-2 cells.
(B) Light microscopic quantitation of autophagy in HT-29 control cells and HT-29 Bcl-2 cells transfected with GFP-LC3. Results shown
represent mean ±SEM for combined data from three independent experiments.
(C) Electron microscopic quantitation of autophagy in HT-29 control cells and HT-29 Bcl-2 cells. Results shown represent the mean ±SEM
number of autophagosomes per cell profile for 50 cell profiles per condition.
(D) Representative electron micrographs of HT-29 control and HT-29 Bcl-2 cells. Arrows denote autophagosomes (black, early autophago-
some; white, late autophagosome). Scale bars, 1 m.
(E) Autophagic degradation of long-lived cellular proteins in HT-29 control cells and HT-29 Bcl-2 cells. Results shown represent mean ±SEM
for combined data from three independent experiments. The starvation-induced increase in protein degradation in HT-29 control cells was
completely blocked by 10 mM 3-methyladenine (data not shown).
(F) Coimmunoprecipitation of hVps34 with anti-Beclin 1 antibody in HT-29 control and HT-29 Bcl-2 cells.
(G) Representative confocal microscopy images of Beclin 1 expression and GFP-FYVE domain expression in HT-29 and HT-29 Bcl-2 cells
transfected with a plasmid encoding GFP-FYVE, a PI3P binding domain. Beclin 1 was detected using an anti-Beclin 1 primary antibody and a
rhodamine-conjugated secondary antibody. Yellow color represents colocalization of Beclin 1 and GFP-FYVE, which reflects Beclin 1-associated
Class III PI3K activity.
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933Figure 4. ER-Targeted Bcl-2 but not Mitochondrial-Targeted Bcl-2 Inhibits Autophagy in HT-29 and MCF7 Cells
(A) Representative confocal microscopy images of endogenous Beclin 1 colocalization with ER and mitochondria in HT-29 control cells. Beclin
1 was detected using an anti-Beclin 1 primary antibody and a FITC-conjugated secondary antibody. ER and mitochondria were visualized
using ER-Tracker Red and MitoTracker Red, respectively. Yellow color represents colocalization of Beclin 1 and ER (left lower panel) or Beclin
1 and mitochondria (right lower panel).
(B and D) Western blot analyses of Beclin 1, Bcl-2, and β-actin expression in HT-29 control cells (B) and in MC7.beclin 1 cells (D) transfected
with the indicated Bcl-2 expression plasmids.
(C and E) Light microscopic quantitation of autophagy in HT-29 cells (C) and in MCF7.beclin 1 cells (E) cotransfected with GFP-LC3 and
plasmid indicated below x axis. For (C) and (E), the results shown represent mean ±SEM for combined data from three independent experi-
ments. Abbreviations: ER-Bcl-2, ER-targeted Bcl-2; Mito-Bcl-2, mitochondrial-targeted Bcl-2.cantly increased in MCF7 cells expressing Bcl-2 bind-
ing defective mutants of Beclin 1 during growth in nor-
mal culture media (p = 0.003 for Beclin 1Bcl-2 BD
versus wild-type Beclin 1; p = 0.003 for Beclin 1 F123Aversus wild-type Beclin 1; t test), indicating that these
mutants increase levels of basal autophagy in the ab-
sence of starvation or treatment with a specific auto-
phagy stimulus. Similar levels of Beclin 1 protein were
Cell
934Figure 5. bcl-2 Gene Silencing Increases Levels of Starvation-Induced Autophagy in HeLa Cells, and Bcl-2 Transgenic Expression Reduces
Levels of Starvation-Induced Autophagy in Mouse Heart Muscle
(A) Coimmunoprecipitation of Beclin 1 and Bcl-2 in HeLa cells. Cells were either grown in normal media (lanes 1 and 2), nutrient-rich media
(lane 3), or starvation media (lane 4) for 4 hr prior to coimmunoprecipitation with preimmune goat serum (lane 1) or a goat polyclonal anti-
Beclin 1 antibody (lanes 2–4).
(B) Western blot analysis of Bcl-2 and β-actin expression in HeLa cells transfected with a plasmid encoding a control scrambled siRNA or
siRNA against Bcl-2.
(C) Light microscopic quantitation of autophagy in HeLa cells co-transfected with GFP-LC3 and control siRNA or with GFP-LC3 and bcl-2
siRNA. Results shown represent the mean ±SEM for combined data from three independent experiments.
(D) Western blot analyses of human Bcl-2 and mouse β-actin expression in wild-type and Bcl-2 transgenic mouse heart homogenates.
(E) Representative images of GFP-LC3 staining and (F) quantitation of GFP-LC3-positive dots in cardiac muscle of mice following 48 hr of
starvation. Results shown in (F) represent the mean ±SEM for approximately 20 images obtained per mouse for eight mice of each genotype.
Arrows in (E) denote representative GFP-LC3-positive punctate dots. Scale bars, 5 M.expressed in MCF7 cells transfected with wild-type and
mutant forms of Beclin 1 (Figure 6C), suggesting that
the increased level of autophagy in MCF7 cells trans-
fected with Bcl-2 binding defective mutants of Beclin
1 could not be explained by higher levels of protein
expression. Rather, the increased autophagy in these
cells likely represents a failure of endogenous Bcl-2-
like proteins to downregulate Beclin 1-dependent au-
tophagy. No obvious differences were detected in the
amount of hVps34 that coimmunoprecipitated with
wild-type Beclin 1 versus Bcl-2 binding defective mu-
tants of Beclin 1 (data not shown), suggesting that the
increased autophagic activity of these mutants is not
due to increased formation of Beclin 1/hVps34 com-
plexes.
We investigated whether the increased levels of au-
tophagy triggered by Bcl-2 binding defective Beclin 1
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Butants during normal growth conditions affected the
urvival of MCF7 cells. The viability of MCF7 cells trans-
ected with wild-type Beclin 1 or the control mutant
rotein Beclin 1 I125A was similar to that observed in
CF7 cells transfected with a control empty vector
Figure 6D). In contrast, the Bcl-2 binding defective mu-
ants of Beclin 1, Beclin 1Bcl-2BD or Beclin 1 F123A,
ncreased cell death both during growth in normal con-
itions (p < 0.001; t test) and when cells were starved
or 4 hr (p < 0.001; t test). Of note, the Bcl-2 binding
efective mutants also increased cell death when
ransfected into other cell types, including HEK293
ells, NIH3T3 cells, and COS7 cells (data not shown)
ndicating that this prodeath effect is not limited to cells
uch as MCF7 that have a mutation in caspase-3.
We examined whether the cell death induced by
cl-2 binding defective Beclin 1 mutants could be
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935Figure 6. Beclin 1 Mutants that Cannot Bind to Bcl-2 Induce Higher Levels of Autophagy and Promote atg5-Dependent Cell Death in MCF7
Cells
(A) Coimmunoprecipitation of Beclin 1 mutants and Bcl-2 in HEK293 cells cotransfected with indicated plasmids.
(B) Light microscopic quantitation of autophagy in MCF7.control cells cotransfected with GFP-LC3 and beclin 1 expression plasmid indicated
below x axis. Results shown represent the mean ±SEM for combined data from three independent experiments.
(C) Western blot analysis of Flag-Beclin 1 and β-actin expression in MCF7 cells 30 hr after transfection with indicated plasmids.
(D) Quantitation of cell death by trypan blue exclusion 30 hr after transfection with the indicated plasmids in MCF7.control cells growing in
normal media or subjected to 4 hr of starvation.
(E) Western blot analysis of Atg5 and β-actin expression in MCF7.control cells 30 hr after transfection with a plasmid encoding either a control
siRNA or an siRNA against atg5.
(F) Quantitation of cell death by trypan blue exclusion in MCF7.control cells 30 hr after transfection with the indicated Beclin 1 expression
plasmids and a plasmid containing either control siRNA or atg5 siRNA. Cells were either maintained in normal media or subjected to 4 hr of
starvation prior to cell death quantitation. For (D) and (F), results shown represent mean ±SEM for combined data from three independent
experiments. For (C–F), assays were performed on total MCF7 cell populations; using a GFP expression plasmid to measure transfection
efficiency, MCF7 cell transfection efficiency was estimated to range between 50% and 60%.
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936blocked by siRNA directed against a downstream au-
tophagy gene, atg5, that functions in autophagosome
formation (Mizushima et al., 2001). At 30 hr after trans-
fection, at the time of cell death quantitation, Atg5 pro-
tein expression was significantly reduced in MCF7 cells
transfected with a plasmid encoding a hairpin siRNA
against atg5 as compared to cells transfected with a
plasmid encoding a control hairpin siRNA (Figure 6E).
Atg5 siRNA but not control siRNA blocked cell death
induced by Beclin 1Bcl-2BD and Beclin 1 F123A both
during growth in normal media and following a 4 hr
starvation period (Figure 6F). Thus, the downstream au-
tophagy gene, atg5, is required for cell death induced
by mutant forms of Beclin 1 that cannot bind to Bcl-2.
Discussion
Bcl-2 Antiapoptotic Proteins Inhibit Autophagy
In Vitro and In Vivo
Our results demonstrate that both cellular Bcl-2 and
viral Bcl-2 encoded by Kaposi’s sarcoma-associated
herpesvirus inhibit the lysosomal degradation pathway
of autophagy. The enforced expression of either Bcl-2
or KSHV vBcl-2 decreased levels of starvation-induced
autophagy in yeast and mammalian cells. In addition,
transgenic Bcl-2 expression reduced levels of starva-
tion-induced autophagy in mouse cardiomyocytes, in-
dicating that the autophagy inhibitory function of Bcl-2
occurs in vivo and not only in vitro. Furthermore, siRNA
silencing of endogenous Bcl-2 in HeLa cells increased
levels of starvation-induced autophagy, suggesting that
basal levels of Bcl-2 play a role in the regulation of au-
tophagy.
Our observation that Bcl-2 inhibits starvation-induced
autophagy in multiple different cell types and both in
vitro and in vivo suggests that it is a physiologically
important regulator of autophagy. Previous studies
have indirectly implicated a role for Bcl-2 in the nega-
tive regulation of autophagy (Levine and Yuan, 2005).
Bcl-2 has been shown to block caspase-independent
cell death and the degradation of mitochondria, which
are two processes postulated to involve autophagy.
However, direct evidence that Bcl-2 inhibits the auto-
phagy pathway has been lacking.
The biological effects of Bcl-2 have been largely at-
tributed to its effects on the apoptotic pathway, al-
though it has been recognized that Bcl-2 family mem-
bers are multifunctional proteins that can influence
other cellular processes, including cell cycle pro-
gression, calcineurin signaling, glucose homeostasis,
and transcriptional repression by p53 (Danial and Kors-
meyer, 2004; Reed, 1998). Our results suggest that
Bcl-2 antiapoptotic family members also target the au-
tophagy pathway. This concept has important implica-
tions for diverse aspects of biology, since autophagy
genes play a role in promoting survival during stress
conditions, in differentiation and development, in life-
span extension, in tumor suppression, and in cell death
in apoptosis-deficient cells (Levine and Klionsky, 2004;
Levine and Yuan, 2005). Therefore, the inhibition of au-
tophagy by cellular and virally-encoded Bcl-2 antiapo-
ptotic family members may represent a novel mecha-
nism by which Bcl-2 family members function as
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odulate various homeostatic, developmental, and
isease processes.
In contrast to our findings that Bcl-2 functions as an
nhibitor of autophagy, a recent study demonstrated an
pposite role for Bcl-2 antiapoptotic family members in
he regulation of autophagy. Shimizu et al. (2004) re-
orted that Bcl-xL or Bcl-2 overexpression increases
utophagy in transformed MEFs treated with etopo-
ide. The basis for the differences between these data
nd our findings is not yet clear. It is possible that Bcl-2
amily members vary in their regulatory effects on
utophagy depending on the cell type or stimulus.
owever, it is worth noting that etoposide is not a phys-
ological inducer of autophagy and that etoposide
nduces apoptosis rather than autophagy gene-depen-
ent death in most cell types. In our study, we focused
n the role of Bcl-2 in starvation-induced autophagy,
ince starvation is an important physiologic inducer of
utophagy across a broad range of eukaryotic species.
urthermore, autophagy plays a prosurvival rather than
rodeath role during starvation, thereby allowing us to
issociate the inhibitory effects of Bcl-2 on cell death
rom its effects on autophagy. Our findings demon-
trate that at least during starvation, Bcl-2 functions to
nhibit, rather than promote, autophagy. Other studies
sing different physiological stimuli of autophagy are
equired to determine whether the inhibitory effects of
cl-2 are restricted to nutrient deprivation or whether
cl-2 plays a more general role in the negative regula-
ion of autophagy.
cl-2 Inhibits Autophagy via an Interaction
ith Beclin 1
ur results suggest that the mechanism by which Bcl-2
nhibits autophagy is likely to involve its interaction with
eclin 1. We found that Bcl-2-mediated inhibition of
eclin 1-dependent autophagy is prevented by either
utations in Bcl-2 that block binding to Beclin 1 or by
utations in Beclin 1 that block binding to Bcl-2. Al-
hough the specific BH1-domain and BH2-domain
cl-2 mutant proteins used in this study also fail to bind
o proapoptotic Bcl-2 family members (Sedlak et al.,
995; Yin et al., 1994), we found that these mutants
ailed to inhibit Beclin 1-dependent autophagy in yeast
ells that lack any endogenous pro- or antiapoptotic
cl-2-like family members. This observation argues
trongly for an independent role of Bcl-2-Beclin 1 in-
eractions in the inhibition of autophagy.
In HT-29 cells, the inhibitory effects of Bcl-2 are asso-
iated with disruption of the Beclin 1/hVps34 com-
lexes, which are thought to be essential for early
tages of autophagosomal formation (Kihara et al.,
001). However, in MCF7 cells, the increased auto-
hagy induced by Bcl-2 binding defective mutants of
eclin 1 are not associated with increased binding of
Vps34 to the Beclin 1 mutants. Therefore, it is possible
hat the mechanism by which Bcl-2 inhibits the auto-
hagy function of Beclin 1 involves either the disruption
f Beclin 1/hVps34 complex formation or antagonism
f other as-of-yet-defined actions of Beclin 1 that are
ecessary for autophagy. In either case, it is unlikely
hat there is direct competition between Bcl-2 and
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937Figure 7. Model of a Rheostat Function of the Beclin 1-Bcl-2 Complex in Autophagy Regulation
Physiological levels of autophagy (shaded region of center graph) are essential for normal cellular homeostasis, and the absence of autophagy
genes (shaded region of left graph) increases cell death during nutrient deprivation and other forms of cellular stress (reviewed in Levine and
Klionsky [2004]). In contrast, excessive, nonphysiological levels of autophagy (shaded region of right graph) promote autophagy gene-depen-
dent cell death. The relative amounts of Beclin 1 and Bcl-2 (or perhaps other Bcl-2 family members) complexed with each other within a cell
govern the threshold for transition from cell homeostasis (center graph) to cell death (right graph).hVps34 for binding to Beclin 1 since the subcellular lo-
calization of Bcl-2 and hVps34 are not known to over-
lap. In this study, we found that some endogenous Bec-
lin 1 localizes to the ER and that ER-targeted Bcl-2
effectively inhibits autophagy in both HT-29 and MCF7
cells. It is possible that Bcl-2 results in a redistribution
of Beclin 1 away from the TGN (where it is active in
autophagy induction; Kihara et al., 2001) to the ER;
however, we did not observe any differences in the
amount of Beclin 1 localized to the ER in cells that ex-
press low or high levels of Bcl-2 (data not shown). More
likely, the interaction between Bcl-2 and Beclin 1 in the
ER blocks a signal that is essential for autophagy in-
duction.
The ability of Bcl-2 to inhibit autophagy through a
direct interaction with Beclin 1 is of particular interest
with respect to cancer. Bcl-2 was originally discovered
in the context of its translocation next to the immuno-
globulin gene promoter at the chromosomal breakpoint
of t(14;18) bearing human follicular lymphoma, and
transgenic mice harboring a Bcl-2 immunoglobulin min-
igene develop follicular hyperplasia (Danial and Kors-
meyer, 2004). Of note, deletion of one allele of beclin
1 predisposes mice to developing spontaneous B cell
lymphomas, suggesting that levels of Beclin 1-medi-
ated autophagy influence the risk of malignancies aris-
ing from B lymphocytes (Qu et al., 2003; Yue et al.,
2003). Thus, in addition to inhibitory effects on the ca-
nonical apoptosis pathway, the inhibitory effects of Bcl-2
on Beclin 1-dependent autophagy may contribute to
the development of B cell lymphomas. Furthermore,
given our findings that the viral Bcl-2 encoded by KSHV
inhibits Beclin 1-dependent autophagy, it will also be
important to determine the role of viral Bcl-2-Beclin 1
interactions in oncogenesis mediated by KSHV and
other γherpesviruses.
The finding that Bcl-2 inhibits Beclin 1-dependent au-
tophagy raises the question of how physiological au-
tophagy occurs in normal cells that express both Bcl-2
and Beclin 1. Our results suggest that cellular nutrient
conditions that regulate autophagy also regulate the in-
teraction of Bcl-2 and Beclin 1. When autophagy ismaximally induced by amino acid starvation, Bcl-2
binding to Beclin 1 is minimal, and when autophagy is
inhibited by amino acid excess, Bcl-2 binding to Beclin
1 is maximal. Thus, the dissociation of Bcl-2 from Bec-
lin 1 may be an important mechanism for activating au-
tophagy in response to starvation and potentially other
physiological stimuli. Conversely, the association of
Bcl-2 and Beclin 1 during normal growth conditions
may be a mechanism for preventing inappropriate acti-
vation of autophagy. This concept is consistent with our
observation that Bcl-2 binding defective mutants of
Beclin 1 promote increased levels of autophagy in the
absence of starvation.
It is not yet known how nutrient conditions regulate
the interaction between Bcl-2 and Beclin 1. Since we
found that Bcl-2 functions at the ER to inhibit auto-
phagy and previous studies have shown that phosphor-
ylated Bcl-2 localizes predominantly to the ER (Bassik
et al., 2004), one intriguing possibility is that Bcl-2 may
be a target for autophagy-inhibitory signaling kinases
involved in nutrient sensing. For example, Bcl-2 has
been noted to be phosphorylated following addition of
growth factors (Poommipanit et al., 1999) and dephos-
phorylated following treatment with rapamycin, a phar-
macological inhibitor of the evolutionarily conserved
nutrient sensor, TOR kinase, that functions downstream
of growth factor-signaling molecules to suppress au-
tophagy (Asnaghi et al., 2004). While yeast genetic
studies have indicated that autophagy genes are down-
stream of TOR (Noda and Ohsumi, 1998), the relevant
targets of TOR in autophagy suppression are not yet
defined. Given our observation that cellular nutrient
status regulates formation of the autophagy inhibitory
Bcl-2-Beclin complex, it will be important to determine
whether modulation of the Bcl-2-Beclin 1 interaction by
TOR kinase or other nutrient signaling pathways is in-
volved in autophagy suppression.
Bcl-2 Inhibition of Beclin 1 Autophagy Function May
Prevent Autophagy Gene-Dependent Cell Death
We found that mutant proteins of Beclin 1 that cannot
bind to Bcl-2 induce excess levels of cellular autophagy
Cell
938in the absence of exposure to nutrient deprivation or
other specific autophagy stimuli. These excess levels
of autophagy are associated with the induction of a
form of cell death that can be prevented by siRNA di-
rected against atg5, a downstream autophagy gene,
suggesting that at “nonphysiological” levels, the au-
tophagy pathway can lead to cell death. These obser-
vations lead to the hypothesis that Bcl-2 downregula-
tion of autophagy, through its interaction with Beclin 1,
may prevent autophagy from occurring at elevated
levels that promote cell death.
Based upon these findings and previous evidence
that ATG6/beclin 1 family members and other auto-
phagy genes promote cellular survival during starvation
(Boya et al., 2005; Levine and Klionsky, 2004), we pro-
pose a conceptual model for understanding the interre-
lationship between autophagy, cell survival, and cell
death (Figure 7). According to this model, autophagy is
necessary as an adaptive response to nutrient depriva-
tion and other forms of cellular stress, and the absence
of autophagy increases susceptibility to death when
cells confront stressful stimuli. However, if levels of au-
tophagy are induced beyond a physiological range, the
autophagy pathway can contribute to death execution.
Our results suggest that the Beclin 1-Bcl-2 complex
may function as rheostat that ensures that autophagy
levels remain within a homeostatic range rather than in
a nonphysiological range that triggers cell death. When
Beclin 1 is bound to Bcl-2 (or potentially other Bcl-2
family members), cells respond to autophagy-inducing
stimuli in a regulated manner. However, when Beclin 1
function is “unchecked” by Bcl-2-like proteins, exces-
sive levels of autophagy may promote cell death. Thus,
similar to the theory that the relative concentrations of
Bcl-2 pro- and antiapoptotic family members govern
the threshold for activation of apoptosis in a given cell,
we propose that the relative concentration (or binding)
of Bcl-2 and Beclin 1 govern the threshold for activation
of autophagy and autophagy-gene-dependent cell
death.
Experimental Procedures
Please see Supplemental Experimental Procedures for information
on yeast strains, plasmid constructions, siRNA suppression of
gene expression, Western blot analyses, confocal microscopy, and
more details on coimmunoprecipitation assays.
Cell Culture
HEK293 and HeLa cells were obtained from ATCC (American Type
Culture Collection, Rockville, Maryland). MCF7.control cells and
MCF7.beclin 1 cells were previously described (Furuya et al., 2005).
HT-29 cells stably transfected with a plasmid containing human
bcl-2 (HT-29 Bcl-2 cells) or empty vector (HT-29 control cells) were
previously described (Lacour et al., 2003).
Mouse Strains
Cardiac-specific Bcl-2 transgenic mice (Imahashi et al., 2004) were
crossed with GFP-LC3 transgenic mice (Mizushima et al., 2004).
Two-month-old offspring of either sex were used for autophagy ex-
periments.
Yeast Two-Hybrid Assays
pGBT9 plasmids containing cellular bcl-2 or KSHV v-bcl-2 were
cotransformed with pGAD424 plasmids containing beclin 1 in
S. cerevisiae SFY526 cells, and transformants were screened for
LacZ activity by a colony lift filter assay.
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Cutophagy Assays
east autophagy was measured in cells subjected to 4 hr of starva-
ion using differential interference contrast (DIC) microscopy as de-
cribed (Talloczy et al., 2002).
Mammalian autophagy in MCF7 cells, HT-29 cells, and HeLa cells
as measured by light microscopic quantitation of cells trans-
ected with GFP-LC3 as described (Furuya et al., 2005). For most
xperiments, the percentage of GFP-LC3-positive cells with GFP-
C3 punctate dots was determined. However, in experiments re-
uiring a precise assessment of levels of autophagy per cell, the
umber of GFP-LC3 punctate dots per cell in GFP-LC3-positive
ells was determined. A minimum of 50–100 cells per sample was
ounted for triplicate samples per condition per experiment. Prior
o analysis, cells were starved for 4 hr in Earle’s balanced salt solu-
ion (EBSS; starvation medium), cultured in EBSS supplemented
ith 10% fetal calf serum and a 10× amino acid mixture (nutrient-
ich medium), or maintained in DMEM with 10% fetal calf serum
normal media). In HT-29 control and HT-29 Bcl-2 cells, the degra-
ation of radioactive C14valine-labeled long-lived proteins was
easured as described (Pattingre et al., 2004). Electron microscopic
EM) analyses of autophagy in HT-29 control and HT-29 Bcl-2 cells
ere performed as described (Liang et al., 2001).
Autophagy was measured in the hearts of Bcl-2 trangenic/GFP-
C3 and non-Bcl-2 transgenic control/GFP-LC3 mice following 48
r of starvation as described (Qu et al., 2003). All animal studies
ere performed in accordance with UT Southwestern Institutional
nimal Care and Use Committee Guidelines.
oimmunoprecipitation Assays
eclin 1-Bcl-2 coimmunoprecipitations were performed in HEK293
ells using an anti-Flag antibody or an anti-His antibody to immu-
oprecipitate epitope-tagged Beclin 1. To immunoprecipitate en-
ogenous Beclin 1, a rabbit polyclonal anti-Beclin 1 antibody (No-
us Biologicals, Littleton, Colorado) was used in HT-29 control and
T-29 Bcl-2 cells, and a goat polyclonal antibody was used in HeLa
ells (Santa Cruz Biologicals, Santa Cruz, California). Coimmuno-
recipitation of Beclin 1 and hVps34 was performed as described
Furuya et al., 2005)
ell Death Assays
CF7.control cells were transfected using Lipofectamine 2000 (In-
itrogen, Carlsbad, California) with pCR3.1 plasmids expressing
ild-type or mutant forms of Beclin 1 alone (4 g DNA) or in combi-
ation with control or atg5 pSilencer 4.1-CMV puro vectors (2 g
NA of each vector). Thirty hours after transfection, cell viability
as measured by trypan blue exclusion. A minimum of 100 cells
er sample for triplicate samples was counted per condition per
xperiment.
upplemental Data
upplemental Data include Supplemental Experimental Procedures
nd can be found with this article online at http://www.cell.com/
gi/content/full/122/6/927/DC1/.
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